FIELD: biotechnology.
SUBSTANCE: invention relates to dimers of constructed polypeptides binding to a neonatal FcRn receptor Fc containing a FcRn-binding motif EX2X3X4AX6X7EIRWLPNLX16X17X18QRX21AFIX25X26LX28X29, where X2 is selected from A, D, E, F, H, I, K, L, N, Q, R, S, T, V, W and Y; X3 selected from A, D, E, F, G, H, I, K, L, M, N, Q, R, S, T, V, W and Y; X4 is selected from A, D, E, F, G, H, I, K, L, N, Q, R, S, T, V, W and Y; X6 is selected from A, G, K, Q, R, S and V; X7 is selected from A, F, H, K, N, Q, R, S and V; X16 is selected from N and T; X17 is selected from F, W and Y; X18 is selected from A, D, E and N; X21 is selected from A, S, V and W; X25 is selected from D, E, G, H, I, K, L, N, Q, R, S, T, V, W and Y; X26 is selected from K and S; X28 is selected from A, D, E, H, K, L, N, Q, R, S, T, W and Y; and X29 is D.
EFFECT: present invention enables to obtain fused proteins, conjugates and compositions capable of efficiently binding FcRn.
22 cl, 21 tbl, 25 ex, 18 dwg
Title | Year | Author | Number |
---|---|---|---|
IL-17A-BINDING POLYPEPTIDES | 2016 |
|
RU2749712C2 |
ANTIBODIES AGAINST CXCR2 AND THEIR USE | 2019 |
|
RU2807067C2 |
IL-12 HETERODIMERIC FC FUSION PROTEINS | 2019 |
|
RU2819097C2 |
HYBRID PROTEINS OF sPD-1-Fc VARIANT | 2019 |
|
RU2785993C2 |
ANTIBODIES AGAINST PD-L1 AND THEIR OPTIONS | 2017 |
|
RU2770590C2 |
ANTI-PVRIG ANTIBODIES AND METHODS OF USING | 2016 |
|
RU2732042C2 |
ANTI-CLL1-SPECIFIC SINGLE-CHAIN CHIMERIC ANTIGENIC RECEPTORS (SCCAR) FOR CANCER IMMUNOTHERAPY | 2016 |
|
RU2731543C2 |
BISPECIFIC ANTIGEN-BINDING POLYPEPTIDES | 2015 |
|
RU2723940C2 |
POLYPEPTIDE COMPRISING ANTIGEN-BINDING DOMAIN AND TRANSPORT SEGMENT | 2018 |
|
RU2815452C2 |
NEONATAL Fc RECEPTOR BINDING AFFIMERS | 2020 |
|
RU2817008C1 |
Authors
Dates
2020-07-02—Published
2015-09-17—Filed